Jazz Pharma Could Be Worth Over $200 If Xyrem Adds Long-Term Value: Here's How
July 31, 2015 at 10:56 AM EDT
In a report published Friday, Leerink analyst Jason M. Gerberry maintained an Outperform rating on Jazz Pharmaceuticals plc - ...
